Levi & Korsinsky has launched an investigation into Fortress Biotech, Inc. over potential breaches of fiduciary duties. This legal scrutiny could impact current shareholders and the company's governance. Shareholders are encouraged to seek more information or legal advice from the firm at no cost. The investigation highlights concerns about financial management and accountability at Fortress Biotech.
Beasley Broadcast Group has postponed its Q2 2026 financial results announcement and related conference call to allow more time to complete tax accounting related to its recent refinancing and debt restructuring. The company expects to reschedule the...
Rob Hamilton, CEO of AnchorWatch, was conducting AI-powered security audits on Bitcoin code when OpenAI's 'trust cyber program' blocked his access despite completing all verification steps. His volunteer team had identified numerous critical vulnerab...
Meta reported strong ad revenue growth but saw a 14.42% EPS miss and margin compression due to rising costs and legal charges, signaling short-term pain from heavy AI investment. Alphabet outperformed on revenue and EPS, driven by an 82% surge in Goo...
XRP's price dropped to $1, its lowest since July 2024, driven by global economic challenges and declining investor interest. The cryptocurrency has lost over 65% of its value in the past year, with reduced trading volume and token accumulation signal...
A Shenzhen tech employee was sentenced to over three years in prison for stealing company R&D data and demanding ransom in Bitcoin and USDT worth about $87,000. The court's ruling notably recognized Bitcoin and USDT as virtual assets with property va...
